VSee Health (VSEE) Competitors $0.62 -0.05 (-7.15%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$0.60 -0.02 (-3.07%) As of 10/24/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VSEE vs. ACONW, AONC, DHACW, FMS, LFMDP, PIIIW, TALKW, TOIIW, NTRA, and HIMSShould you be buying VSee Health stock or one of its competitors? The main competitors of VSee Health include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. VSee Health vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD P3 Health Partners Talkspace Oncology Institute Natera Hims & Hers Health VSee Health (NASDAQ:VSEE) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Is VSEE or ACONW more profitable? Aclarion has a net margin of 0.00% compared to VSee Health's net margin of -461.61%. Aclarion's return on equity of 0.00% beat VSee Health's return on equity.Company Net Margins Return on Equity Return on Assets VSee Health-461.61% -146.51% -109.08% Aclarion N/A N/A N/A Do analysts prefer VSEE or ACONW? VSee Health currently has a consensus target price of $5.00, indicating a potential upside of 703.73%. Given VSee Health's stronger consensus rating and higher possible upside, analysts plainly believe VSee Health is more favorable than Aclarion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in VSEE or ACONW? 1.0% of VSee Health shares are owned by institutional investors. 6.6% of VSee Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger valuation and earnings, VSEE or ACONW? Aclarion has lower revenue, but higher earnings than VSee Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVSee Health$10.42M0.21-$57.70MN/AN/AAclarion$62.95KN/AN/AN/AN/A Does the media favor VSEE or ACONW? In the previous week, VSee Health had 8 more articles in the media than Aclarion. MarketBeat recorded 9 mentions for VSee Health and 1 mentions for Aclarion. Aclarion's average media sentiment score of 1.89 beat VSee Health's score of 0.70 indicating that Aclarion is being referred to more favorably in the news media. Company Overall Sentiment VSee Health Positive Aclarion Very Positive SummaryVSee Health beats Aclarion on 7 of the 11 factors compared between the two stocks. Get VSee Health News Delivered to You Automatically Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VSEE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VSEE vs. The Competition Export to ExcelMetricVSee HealthINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket CapN/A$19.74B$33.09B$10.67BDividend YieldN/A3.70%3.18%4.82%P/E RatioN/A76.38104.8730.65Price / Sales0.21116.701,290.06174.40Price / CashN/A83.8538.0861.44Price / Book-62.219.277.626.61Net Income-$57.70M$356.34M$820.47M$277.10M7 Day Performance30.36%4.64%2.47%2.55%1 Month Performance-2.78%1.43%3.63%3.77%1 Year Performance-67.43%63.57%24,146.25%33.05% VSee Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VSEEVSee Health3.0063 of 5 stars$0.62-7.1%$5.00+703.7%-66.4%$0.00$10.42M0.00N/ANews CoverageAnalyst ForecastShort Interest ↑Gap UpHigh Trading VolumeACONWAclarionN/A$0.06-44.6%N/AN/A$0.00$62.95K0.007Positive NewsGap DownHigh Trading VolumeAONCAmerican Oncology NetworkN/A$8.70flatN/A+183.9%$0.00$1.34B0.001,520Short Interest ↓DHACWDigital Health AcquisitionN/A$0.03+21.7%N/A-42.4%$0.00N/A0.00N/AGap UpFMSFresenius Medical Care AG & Co. KGaA4.2189 of 5 stars$27.42+0.0%$27.80+1.4%+27.6%$0.00$20.63B22.471,384News CoverageAnalyst UpgradeShort Interest ↓LFMDPLifeMDN/A$23.99+1.1%N/A+7.3%$0.00$245.56M0.00230Positive NewsPIIIWP3 Health PartnersN/A$0.01-1.6%N/A-67.7%$0.00$1.46B0.00500Positive NewsGap DownTALKWTalkspaceN/A$0.08-1.0%N/A-68.4%$0.00$202.61M0.00500Positive NewsHigh Trading VolumeTOIIWOncology InstituteN/A$0.11+4.3%N/A+870.5%$0.00$424.38M0.00660News CoveragePositive NewsHigh Trading VolumeNTRANatera1.7401 of 5 stars$172.81-0.8%$194.06+12.3%+61.5%$23.90B$1.70B0.004,434Trending NewsAnalyst ForecastInsider TradeShort Interest ↑HIMSHims & Hers Health2.1429 of 5 stars$54.12-1.1%$38.92-28.1%+127.0%$12.37B$1.48B101.351,637Analyst ForecastAnalyst RevisionGap Up Related Companies and Tools Related Companies Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors Fresenius Medical Care AG & Co. KGaA Competitors LifeMD Competitors P3 Health Partners Competitors Talkspace Competitors Oncology Institute Competitors Natera Competitors Hims & Hers Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VSEE) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VSee Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VSee Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VSEE Stock Alerts